- Report
- February 2019
- 148 Pages
Global
From €3640EUR$4,175USD£3,165GBP
- Report
- April 2021
- 263 Pages
Global
From €3270EUR$3,750USD£2,843GBP
- Report
- October 2024
- 160 Pages
Global
From €2607EUR$2,990USD£2,267GBP
- Report
- July 2023
- 370 Pages
Global
From €3662EUR$4,200USD£3,184GBP
- Report
- April 2022
- 335 Pages
Global
From €3270EUR$3,750USD£2,843GBP
- Report
- November 2019
- 268 Pages
Global
From €3052EUR$3,500USD£2,654GBP
- Report
- May 2024
- 284 Pages
Global
From €4316EUR$4,950USD£3,753GBP
- Report
- January 2025
- 1012 Pages
Global
From €1428EUR$1,695USD£1,200GBP
- Report
- December 2024
- 1214 Pages
Global
From €1428EUR$1,695USD£1,200GBP
- Report
- March 2023
- 935 Pages
Global
€1428EUR$1,695USD£1,200GBP
- Report
- April 2022
- 555 Pages
Global
From €1190EUR$1,413USD£1,000GBP
- Report
- December 2022
- 123 Pages
Global
From €4795EUR$5,500USD£4,170GBP
- Report
- January 2025
- 175 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- October 2021
- 182 Pages
Asia Pacific
From €2398EUR$2,750USD£2,085GBP
From €4316EUR$4,950USD£3,753GBP
- Report
- February 2020
- 72 Pages
Indonesia
From €2616EUR$3,000USD£2,275GBP
- Report
- September 2023
- 294 Pages
Global
From €2398EUR$2,750USD£2,085GBP
€4795EUR$5,500USD£4,170GBP
- Report
- June 2023
Global
From €4316EUR$4,950USD£3,753GBP
- Report
- October 2024
- 200 Pages
China
From €2171EUR$2,490USD£1,888GBP
- Report
- October 2024
- 200 Pages
United Kingdom
From €2171EUR$2,490USD£1,888GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more